November 15, 2019
Mylan Pharmaceuticals Inc. is recalling a single lot of alprazolam tablets, 0.5 mg. According to the November 13, 2019, US Food and Drug Administration (FDA) Enforcement Report, the recall is due to the presence of a foreign substance.
The recall affects 5760 bottles of 500-count alprazolam tablets, 0.5 mg (NDC 0378-4003-05), from lot 8082708 (Exp. 9/20). The affected alprazolam was distributed throughout the United States.
Mylan Pharmaceuticals voluntarily initiated the recall October 23, 2019. On November 5, 2019, the FDA designated the recall Class II, communicating use of the drug may cause temporary or medically reversible adverse health consequences or a remote possibility of serious harm.
Alprazolam is a prescription benzodiazepine used to treat anxiety and panic disorders.